This upregulation was also seen in pre-cancerous liver tissue, and the knockdown of SNAT1 with siRNA lowered the cell viability in HepG2 cells, indicating a role for SNAT1 in the tumor growth and survival of hepatocellular carcinomas [228]. The gene discussed is SLC38A1; the disease is hepatocellular carcinoma.